Northeast Pharmaceutical Group Co., Ltd. (000597-SZ) Stock Split, History Data
Working capital analysis
In terms of working capital, Northeast Pharmaceutical Group Co., Ltd. maintains a healthy position.
The total current assets of the company are valued at $9783060044.
This represents a growth rate of 23.360% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $5651183181, exhibiting a growth rate of 46.979% year-on-year.
The receivables, another significant portion of the current assets, are valued at $2616560838.
The year-on-year growth rate for receivables is -7.898%.
The inventory, which forms a critical part of the assets, is valued at $1364090227.
This represents a healthy year-on-year growth of 11.773%
On the liabilities side, the company's current liabilities total $9568488034.
This reflects a growth rate of 13.598% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
5651.18
3844.90
2550.41
1481.27
1525.40
1283.58
Receavebles
2616.56
2840.93
2956.79
2777.49
3015.91
2973.22
Inventory
1364.09
1220.42
1247.27
1253.23
1283.77
1271.22
Other
151.23
24.28
44.87
41.16
54.28
65.31
Total Current Assets
9783.06
7930.53
6799.34
5553.15
5879.36
5593.33
Acc Payable
1398.10
4320.49
3695.80
2763.94
2695.74
2522.55
Short Term Debt
6527.42
1976.78
3179.79
3309.53
3784.53
3045.58
Other Current Liab
1511.80
1933.14
10.96
11.93
112.75
1020.28
Current Liabilities
9568.49
8423.13
8198.60
7316.21
7899.25
6651.38
Capital Structure
When examining the capital structure of Northeast Pharmaceutical Group Co., Ltd., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Northeast Pharmaceutical Group Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.
